SOLVAY S.A. UNSP.ADR/1/10 (SOL0) — Defensive Interval Ratio

Latest as of March 2026: 142 days

SOLVAY S.A. UNSP.ADR/1/10 (SOL0) has a Defensive Interval Ratio of 142 days as of March 2026. Defensive assets of €693.00 Million (cash €-, short-term investments €15.00 Million, receivables €678.00 Million) cover 142 days of daily cash needs of €4.89 Million/day. See working capital position of SOLVAY S.A. UNSP.ADR/1/10 to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

142 days
Days of operational coverage

Defensive Assets

€693.00 Million
Cash + ST Investments + Receivables

Daily Cash Need

€4.89 Million
Current Liabilities ÷ 365

Current Liabilities

€1.79 Billion
EUR

SOLVAY S.A. UNSP.ADR/1/10 Defensive Interval Ratio (2022–2025)

This chart shows how SOLVAY S.A. UNSP.ADR/1/10's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 142 days, meaning defensive assets of €693.00 Million can fund 142 days of operations without new revenue. See SOL0 equity to assets ratio to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for SOLVAY S.A. UNSP.ADR/1/10 (2022–2025)

The table below presents the year-by-year Defensive Interval Ratio for SOLVAY S.A. UNSP.ADR/1/10 from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see SOL0 stock market capitalisation.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 127 days €640.00 Million €5.05 Million/day €- €18.00 Million ▼ -36 days
2024 163 days €843.00 Million €5.17 Million/day €- €17.00 Million ▲ +2 days
2023 161 days €967.00 Million €6.01 Million/day €- €127.00 Million ▼ -47 days
2022 208 days €2.78 Billion €13.38 Million/day €- €758.00 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)